| Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11 RM Drayton, E Dudziec, S Peter, S Bertz, A Hartmann, HE Bryant, ... Clinical cancer research 20 (7), 1990-2000, 2014 | 264 | 2014 |
| Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin-and oligofectamine-induced gene expression changes in human epithelial cells Y Omidi, AJ Hollins, M Benboubetra, R Drayton, IF Benter, S Akhtar Journal of drug targeting 11 (6), 311-323, 2003 | 184 | 2003 |
| Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type Y Omidi, AJ Hollins, RM Drayton, S Akhtar Journal of drug targeting 13 (7), 431-443, 2005 | 165 | 2005 |
| An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer S Miah, E Dudziec, RM Drayton, AR Zlotta, SL Morgan, DJ Rosario, ... British journal of cancer 107 (1), 123-128, 2012 | 157 | 2012 |
| Molecular mechanisms of cisplatin resistance in bladder cancer RM Drayton, JWF Catto Expert review of anticancer therapy 12 (2), 271-281, 2012 | 125 | 2012 |
| Inhibition of poly (ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells C Fathers, RM Drayton, S Solovieva, HE Bryant Cell cycle 11 (5), 990-997, 2012 | 102 | 2012 |
| Identification of differentially expressed long noncoding RNAs in bladder cancer S Peter, E Borkowska, RM Drayton, CP Rakhit, A Noon, W Chen, ... Clinical cancer research 20 (20), 5311-5321, 2014 | 64 | 2014 |
| The role of microRNA in the response to cisplatin treatment. RM Drayton Biochemical Society Transactions 40 (4), 2012 | 33 | 2012 |
| MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer RM Drayton, S Peter, K Myers, S Miah, E Dudziec, HE Bryant, JWF Catto Oncotarget 5 (15), 6375, 2014 | 28 | 2014 |
| Identification and diagnostic performance of a small RNA within the PCA3 and BMCC1 gene locus that potentially targets mRNA RM Drayton, I Rehman, R Clarke, Z Zhao, K Pang, S Miah, R Stoehr, ... Cancer Epidemiology, Biomarkers & Prevention 24 (1), 268-275, 2015 | 12 | 2015 |
| The Fanconi anemia pathway is downregulated upon macrophage differentiation through two distinct mechanisms WT Lu, K Lemonidis, RM Drayton, T Nouspikel Cell cycle 10 (19), 3300-3310, 2011 | 11 | 2011 |
| Dendrimeric delivery systems for siRNA and gene therapy intrinsically alter gene expression in human epithelial cells Y Omidi, M Benboubetra, AJ Hollins, R Drayton, S Akhtar Journal of Pharmacy and Pharmacology 56 (S1), 19-19, 2004 | 2 | 2004 |
| Genocompatibility of non-viral vectors for gene-based therapies S Akhtar, Y Omidi, A Hollins, R Drayton, M Benboubetra JOURNAL OF GENE MEDICINE 6 (9), S5-S5, 2004 | 1 | 2004 |
| 426 Identification and diagnostic performance of a small RNA within the PCA3 and BMCC1 gene locus that potentially targets mRNA KH Pang, S Miah, RM Drayton, I Rehman, R Clarke, R Stoehr, ... European Urology Supplements 2 (14), e426-e426b, 2015 | | 2015 |
| 232 Identification of differentially expressed long non-coding RNAs in bladder cancer S Peter, E Borkowska, R Drayton, C Rakhit, A Noon, W Chen, J Catto European Urology Supplements 2 (14), e232, 2015 | | 2015 |
| Identification of Differentially Expressed Long Noncoding S Peter, E Borkowska, RM Drayton | | 2014 |
| Abstract A10: MicroRNA 27a is downreguated in cisplatin resistant bladder cancer cells, and contributes to resistance through the targeting of xCT, a cystine transporter … RM Drayton, E Dudziec, JWF Catto, HE Bryant Cancer Research 72 (2_Supplement), A10-A10, 2012 | | 2012 |
| Drug sensitivity and apoptosis in tamoxifen resistant breast cancer R Drayton PQDT-Global, 2007 | | 2007 |
| Differential sensitivity of tamoxifen resistant and wild type breast cancer cells to the DNA double strand break-causing drugs, etoposide, bleomycin and doxorubicin RM Drayton, R Nicholson, S Akhtar Journal of Pharmacy and Pharmacology 57 (S1), S24, 2005 | | 2005 |
